Effect of rabeprazole and ranitidine in reducing stomach volume in women undergoing cesarean section

Changes in qualitative and quantitative ultrasound assessment of gastric antrum : a comparison study between rabeprazole and ranitidine in patients undergoing elective cesarean section.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010517

Enrollment

Registered

2017-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PREGNANT FEMALES GOING FOR ELECTIVE CESAREAN SECTION

Interventions

Intervention1: RABEPRAZOLE: PROTON PUMP INHIBITOR Control Intervention1: RANITIDINE: H2 RECEPTOR ANTAGONIST

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant females undergoing elective cesarean section with gestational age less than 36 BMI less than 30 ASA 1 TO 2

Exclusion criteria

Exclusion criteria: Multiple gestation. Poly/ oligo hydraminos. Abnormal anatomy of upper GI tract. Morbid obesity. Previous esophageal gastric surgeries.

Design outcomes

Primary

Measure	Time frame
1. Gastric antral cross sectional area in patients on both groups aspiration prophylaxisTimepoint: 1 hour after giving aspiration prophylaxis	—

Secondary

Measure	Time frame
1. Comparison of prevalence of Grade 2 antrum on ultrasound assessment in both the groups. 2. Documented incidence of post operative gastric symptoms like nausea, vomiting, ability to tolerate feeding, in both the groups of patients. Timepoint: 24 hours after giving aspiration prophylaxis	—

Countries

India

Contacts

Public ContactDR KAJAL JAIN

PGIMER

shameem88vengara@gmail.com8281933016

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026